These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases. Yamagamim H, Moriyama M, Matsumura H, Aoki H, Shimizu T, Saito T, Kaneko M, Shioda A, Tanaka N, Arakawa Y. Cancer; 2002 Aug 15; 95(4):824-34. PubMed ID: 12209727 [Abstract] [Full Text] [Related]
7. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. Hsia CY, Huo TI, Chiang SY, Lu MF, Sun CL, Wu JC, Lee PC, Chi CW, Lui WY, Lee SD. Eur J Surg Oncol; 2007 Mar 15; 33(2):208-12. PubMed ID: 17140760 [Abstract] [Full Text] [Related]
12. Hepatocyte growth factor (HGF) in patients with hepatitis B and meningitis. Ozden M, Kalkan A, Demirdag K, Denk A, Kilic SS. J Infect; 2004 Oct 15; 49(3):229-35. PubMed ID: 15337340 [Abstract] [Full Text] [Related]
13. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis. Hong WS, Hong SI, Park SY, Son Y, Lee YS, Chung YH, Yang SK, Suh DJ, Min YI. Anticancer Res; 1995 Oct 15; 15(6B):2777-80. PubMed ID: 8669863 [Abstract] [Full Text] [Related]
14. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma. Hayasaka A, Suzuki N, Fujimoto N, Iwama S, Fukuyama E, Kanda Y, Saisho H. Hepatology; 1996 Nov 15; 24(5):1058-62. PubMed ID: 8903375 [Abstract] [Full Text] [Related]
16. Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma. Sacco R, Leuci D, Tortorella C, Fiore G, Marinosci F, Schiraldi O, Antonaci S. Cytokine; 2000 Jun 15; 12(6):811-4. PubMed ID: 10843770 [Abstract] [Full Text] [Related]
17. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ. J Gastroenterol Hepatol; 2008 Oct 15; 23(10):1541-8. PubMed ID: 18422961 [Abstract] [Full Text] [Related]
19. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. Fujimoto M, Uemura M, Nakatani Y, Tsujita S, Hoppo K, Tamagawa T, Kitano H, Kikukawa M, Ann T, Ishii Y, Kojima H, Sakurai S, Tanaka R, Namisaki T, Noguchi R, Higashino T, Kikuchi E, Nishimura K, Takaya A, Fukui H. Alcohol Clin Exp Res; 2000 Apr 15; 24(4 Suppl):48S-54S. PubMed ID: 10803780 [Abstract] [Full Text] [Related]
20. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group. Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, Takahashi T, Kasukawa R. Am J Gastroenterol; 2000 Apr 15; 95(4):1036-40. PubMed ID: 10763956 [Abstract] [Full Text] [Related] Page: [Next] [New Search]